Nuclear Medicine - A Global Update of Market Trends & Opportunities

Nuclear Medicine - A Global Update of Market Trends & Opportunities

Nuclear medicine facilitates accurate diagnoses of cardiac diseases, blood flow blockages, neurological disorders, and dysfunction of any major body/organ. Gamma Cameras and PET Scanners are the primary imaging devices used for nuclear medicine procedures. Though nuclear medicine faces competition from other methods, their impact is limited. Demand for diagnostic medical imaging modalities is closely interlinked to the number of diagnostic procedures. Growing awareness of PET's clinical utility and its synergistic use with other imaging modalities and ongoing shift to PET-CT imaging and SPECT-CT imaging is one of the key reasons driving the dramatic rise in procedural volumes. In addition, advancements in molecular imaging, evolution of image-guided interventions, as well as aging population continue to fuel growth in the broader medical diagnostics market.

These and other market data and trends are presented in "Nuclear Medicine: A Global Update of Market Trends & Opportunities" by BizAcumen, Inc. Our reports are designed to be most comprehensive in geographic coverage and vertical market analyses.

NUCLEAR MEDICINE BMR-1033


CONTENTS


1. METHODOLOGY 1
Study Reliability and Reporting Limitations 1
Disclaimers 2
Quantitative Techniques & Reporting Level 3

2. GLOBAL MARKET OVERVIEW AND OUTLOOK 4
Market Snapshots 4
Outlook 5
Trends and Issues 5
Market Shifts to Hybrid Imaging 5
PET Makes Inroads into Conventional Gamma Camera Market 5
Diagnostic Imaging Witnesses Dramatic Growth 5
Aging Population and Healthy Reimbursement Drive Procedure
Volumes 6
Technology Innovations Promise Bright Prospects 6
Competition 7
Leading Players in the Worldwide Nuclear Medicine Market: A-
Completive Analysis 8

3. PRODUCT FACTS 9
Nuclear Medicine 9
Gamma Cameras 10
PET Scanners 10
Research and Development 10
Philips and University Medical Center Hamburg-Eppendorf
Develop MRI/PET Imaging Tool 10
Indian Scientists Develop Low-Cost Nuclear Medicine Kit 10

4. CORPORATE DEVELOPMENTS 11
Orbotech to Acquire Danish Diagnostic Development 11
Covidien Imaging Solution Signs Agreement with BioSynthema 11
Digirad Takes Over Ultrascan 11
Triad Isotopes Acquires Three Major Nuclear Pharmacies 12
International Isotopes Acquires Stake in RadQual 12
Teleradiology and National Healthcare Group Enter into Joint
Venture 12
Philips and Bioscan Sign Marketing Agreement 12
Mubadala Signs Contract with Siemens 13
HealthCare Global and GE Healthcare Establish Advanced
Molecular Imaging- Center 13
International Atomic Energy Agency Establishes Gamma Camera
Laboratory 13
Philips Launches MOSAIC HP Imaging System 13
Digirad Launches nSPEEDsm 14
Philips Introduces PET/CT Pulmonary Toolkit 14
Siemens to Introduce New High Definition PET-CT 14
Philips Extends Availability of PET/CT Viewer to iSite PACS
Settings 15
Philips Announces Commercial Availability of JETStream
Workspace 3.0 15
Philips Launches NanoSPECT/CT 15
Philips Announces Improvements to GEMINI TF PET/CT System 15

5. MAJOR PLAYERS 16
Digirad Corporation (USA) 16
GE Healthcare Plc (The United Kingdom) 16
Mallinckrodt, Inc. (USA) 16
Molypharma S.A. (Spain) 16
Orbotech Medical Solutions Ltd. (Israel) 16
Positron Corporation (USA) 17
IS2 Medical Systems (Canada) 17
Siemens Medical Solutions USA, Inc. (USA) 17
Toshiba Medical Systems Corporation (Japan) 17
Toshiba America Medical Systems, Inc. (USA) 17

6. GLOBAL MARKET ANALYTICS 18

7. THE UNITED STATES 21
Nuclear Medicine - Key Features 21
Market Trends 21
Nuclear Medicine Procedures on the Rise 21
Upsurge in Use of PET Scanners 22
Gamma Cameras: Gaining a Niche in Cardiac Imaging 23
Nuclear Cardiology: Primary Growth Propellant 23
Shift Towards Hospital-based PET Procedures from Outpatient
Facilities 23
Growth in PET Procedure Volumes: Key Market Driver 24
Reimbursement Scenario 24
Competition 24
Gamma Cameras 24
PET Scanners 26

8. CANADA 29
Canada Faces Serious Issue over Paucity of PET Scanners 29

9. JAPAN 30
Market Scenario 30

10. EUROPE 31

a. France 34

b. Germany 35

c. The United Kingdom 36

d. Italy 38

e. Spain 39

f. Rest of Europe 40

11. ASIA-PACIFIC 41
Market Overview 41
Major Markets 41
China 41
Korea 41

12. REST OF WORLD 42
Major Markets 42
The Middle East 42
Latin America 43


EXHIBITS

Table 1: Percentage Breakdown of Leading Players in the Global
Gamma Camera Market - 2007

Table 2: Percentage Breakdown of Leading Players in the
Global PET Scanner Market -2007

Table 3: Estimated Prices of Nuclear Medicine Systems

Table 4: Global Nuclear Medicine Market by Region for the
Period 2007-2015 (Sales in US$ Million)

Table 5: Percentage Breakdown (Value Sales) of Global Nuclear
Medicine Market by Region for the Years 2008 & 2012

Table 6: Global Gamma Cameras Market by Region for the Period
2007-2015 (Sales in US$ Million)

Table 7: Percentage Breakdown (Value Sales) of Global Gamma
Cameras Market by Region for the Years 2008 & 2012

Table 8: Global PET Scanners Market by Region for the Period
2007-2015 (Sales in US$ Million)

Table 9: Percentage Breakdown (Value Sales) of Global PET
Scanners Market by Region for the Years 2008 & 2012

Table 10: Nuclear Medicine Procedures Performed in the US by
Procedure Type - 2007-2010 (in millions)

Table 11: Percentage Breakdown of Leading Players in the US
Gamma Camera Market - 2007E

Table 12: Percentage Breakdown of Leading Players in the US
Cardiology Gamma Camera Market - 2007

Table 13: Percentage Breakdown of Leading Players in the US
PET Scanner Market - 2007

Table 14: Nuclear Medicine Market by Product Segment in the
US: 2007-2015 (Sales in Units)

Table 15: Percentage Breakdown (Volume Sales) of Nuclear
Medicine Market by Product Segment in the US for the Years
2008 & 2012

Table 16: Nuclear Medicine Market by Product Segment in the
US: 2007-2015 (Sales in US$ Million)

Table 17: Percentage Breakdown (Value Sales) of Nuclear
Medicine Market by Product Segment in the US for the Years
2008 & 2012

Table 18: Nuclear Medicine Market by Product Segment in
Canada: 2007-2015 (Sales in US$ Million)

Table 19: Percentage Breakdown (Value Sales) of Nuclear
Medicine Market by Product Segment in Canada for the Years
2008 & 2012

Table 20: Nuclear Medicine Market by Product Segment in Japan:
2007-2015 (Sales in US$ Million)

Table 21: Percentage Breakdown (Value Sales) of Nuclear
Medicine Market by Product Segment in Japan for the Years
2008 & 2012

Table 22: Nuclear Medicine Market by Region in Europe:
2007-2015 (Sales in US$ Million)

Table 23: Percentage Breakdown (Value Sales) of Nuclear
Medicine Market by Region in Europe for the Years 2008 & 2012

Table 24: Nuclear Medicine Market by Product Segment in
Europe: 2007-2015 (Sales in US$ Million)

Table 25: Percentage Breakdown (Value Sales) of Nuclear
Medicine Market by Product Segment in Europe for the Years
2008 & 2012

Table 26: Nuclear Medicine Market by Product Segment in
France: 2007-2015 (Sales in US$ Million)

Table 27: Percentage Breakdown (Value Sales) of Nuclear
Medicine Market by Product Segment in France for the Years
2008 & 2012

Table 28: Nuclear Medicine Market by Product Segment in
Germany: 2007-2015 (Sales in US$ Million)

Table 29: Percentage Breakdown (Value Sales) of Nuclear
Medicine Market by Product Segment in Germany for the Years
2008 & 2012

Table 30: Percentage Breakdown of Nuclear Medicine Market by
Technology in the UK - 2004

Table 31: Nuclear Medicine Market by Product Segment in the
UK: 2007-2015 (Sales in US$ Million)

Table 32: Percentage Breakdown (Value Sales) of Nuclear
Medicine Market by Product Segment in the UK for the Years
2008 & 2012

Table 33: Nuclear Medicine Market by Product Segment in Italy:
2007-2015 (Sales in US$ Million)

Table 34: Percentage Breakdown (Value Sales) of Nuclear
Medicine Market by Product Segment in Italy for the Years 2008
& 2012

Table 35: Nuclear Medicine Market by Product Segment in Spain:
2007-2015 (Sales in US$ Million)

Table 36: Percentage Breakdown (Value Sales) of Nuclear
Medicine Market by Product Segment in Spain for the Years 2008
& 2012

Table 37: Nuclear Medicine Market by Product Segment in Rest
of Europe: 2007-2015 (Sales in US$ Million)

Table 38: Percentage Breakdown (Value Sales) of Nuclear
Medicine Market by Product Segment in Rest of Europe for the
Years 2008 & 2012

Table 39: Nuclear Medicine Market by Product Segment in
Asia-Pacific: 2007-2015 (Sales in US$ Million)

Table 40: Percentage Breakdown (Value Sales) of Nuclear
Medicine Market by Product Segment in Asia-Pacific for the
Years 2008 & 2012

Table 41: Nuclear Medicine Market by Product Segment in Rest
of World: 2007-2015 (Sales in US$ Million)

Table 42: Percentage Breakdown (Value Sales) of Nuclear
Medicine Market by Product Segment in Rest of World for the
Years 2008 & 2012


COMPANIES PROFILED